Zheshang Securities(SH:601878) Xin Lang Cai Jing·2025-10-16 02:21Core Viewpoint - The stock of Beijing Hotgen Biotech Co., Ltd. increased by 5.13% on October 16, reaching a price of 179.55 CNY per share, with a trading volume of 320 million CNY and a turnover rate of 1.95%, resulting in a total market capitalization of 16.646 billion CNY [1] Company Overview - Beijing Hotgen Biotech Co., Ltd. was established on June 23, 2005, and went public on September 30, 2019. The company is located in the Daxing Biomedical Industry Base of Zhongguancun Science Park, Beijing [1] - The main business activities include the research, development, production, and sales of in vitro diagnostic reagents and instruments. The revenue composition is as follows: testing reagents 70.87%, testing instruments 19.79%, others 8.17%, and biological raw materials 1.17% [1] Fund Holdings - According to data, one fund under Zheshang Securities Asset Management has a significant holding in Hotgen Biotech. The Zheshang Huijin Quantitative Selected Mixed Fund (006449) held 36,600 shares in the second quarter, accounting for 4.96% of the fund's net value, making it the fourth-largest holding [2] - The fund has a current scale of 104 million CNY and has achieved a return of 55.66% year-to-date, ranking 536 out of 8161 in its category. Over the past year, the return was 49.56%, ranking 1203 out of 8021, and since inception, the return is 51.94% [2] Fund Manager Information - The fund manager of Zheshang Huijin Quantitative Selected Mixed Fund (006449) is Pang Yaqing, who has been in the position for 1 year and 262 days. The total asset size of the fund is 104 million CNY, with the best return during the tenure being 60.13% and the worst return being -11.71% [3]